Gastro-Intestinal Disorder
Conditions
Brief summary
Fructose is increasingly present in our food. The increase in its consumption is associated with the increase in the prevalence of several pathologies such as metabolic syndrome or hepatic steatosis. The effect of fructose consumption on brain health has been poorly studied. Studies in animal models show that diets enriched in fructose promote the development of emotional behavior disorders. Fructose malabsorption is also associated with changes in the microbiota that could also impact brain health. However, no human study to date has associated fructose malabsorption with changes in the gut microbiota and effects on brain health. The objective of this study is to study the emotional behavior of a population of healthy volunteers according to the presence or not of fructose malabsorption. Patients with fructose malabsorption are susceptible to gut dysbiosis without necessarily consuming high amounts of fructose.
Interventions
OTHERFructose respiratory test
Healthy volunteers will performed a fructose respiratory test in order to evaluate if they are or not fructose malabsorbing. The two population will be compared about their feelings and their micriobiote.
Sponsors
University Hospital, Rouen
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Intervention model description
This study is a monocentric, prospective, non-randomized, comparative assay in which volontarees are enrolled in order to study the fructose effects on intestinal microbiote and their consequencies on the emotions and the neuroinflammation.
Eligibility
Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes
Inclusion criteria
* Healthy volunteers * Aged 18 to 35 * Male sex * BMI between 18.5 and 25 * Affiliation to a social security scheme * Adult patient having read and understood the information letter and signed the consent form
Exclusion criteria
* Presence of irritable bowel syndrome, celiac disease * Presence of a psychiatric illness * Presence of a neurodegenerative disease * Presence of an eating disorder * Presence of chronic disease, including inflammatory disease * Presence of diabetes * Presence of an acute infectious disease * Presence of a surgical history of the digestive tract (excluding appendectomy) * Taking long-term treatment * Taking antibiotics within 6 months * Taking probiotics within 3 months * Typical diet low in lactose, FODMAP, gluten, vegetarian, vegan, vegan, chromonutrition .... in progress * Smoker * Person deprived of liberty by an administrative or judicial decision or person placed under judicial protection / under guardianship or guardianship * Simultaneous participation in another interventional clinical trial
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Evaluate the chronic effect of fructose on anxiety in healthy volunteers with fructose malabsorption compared to healthy volunteers without fructose malabsorption. | Day 1 | Spielberger State Anxiety Questionnaire Score (STAI) with 20 items rated from 1(none) to 4 (a lot). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Evaluate the fructose consumption in healthy volunteers with fructose malabsorption compared to healthy volunteers without fructose malabsorption. | For 7 days before day 30 | Usual fructose consumption assessed by dietary log over 7 days |
| Evaluate the chronic effect of fructose on depression in healthy volunteers with fructose malabsorption compared to healthy volunteers without fructose malabsorption. | Day 1 | HAD score (Hospital Anxiety and Depression Scale) with a minimum score of 0 and a maximum of 42. 14 items. |
| Evaluate the chronic effect of fructose on low-grade intestinal inflammation in healthy volunteers with fructose malabsorption compared to healthy volunteers without fructose malabsorption. | up to 1 month | Spielberger State Anxiety Questionnaire Score (STAI) with 20 items rated from 1(none) to 4 (a lot). |
| Evaluate the chronic effect of fructose on microbiota's composition in healthy volunteers with fructose malabsorption compared to healthy volunteers without fructose malabsorption. | up to 1 month | Amplicon sequencing of the V3-V4 area (region) of bacterial 16S rRNA in volunteer's faeces |
Countries
France
Contacts
PRINCIPAL_INVESTIGATORChloé Melchior
University Hospital, Rouen
Outcome results
None listed